Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q424751> ?p ?o }
Showing triples 1 to 66 of
66
with 100 triples per page.
- Q424751 subject Q7164756.
- Q424751 subject Q8256456.
- Q424751 subject Q9052323.
- Q424751 subject Q9052781.
- Q424751 abstract "Eflornithine (α-difluoromethylornithine or DFMO) is a drug found to be effective in the treatment of facial hirsutism (excessive hair growth) as well as in African trypanosomiasis (sleeping sickness). Eflornithine hydrochloride cream for topical application is meant for women affected by facial hirsutism. Eflornithine for injection against sleeping sickness is manufactured by Sanofi Aventis and sold under the brand name Ornidyl in the USA. Both are prescription drugs.It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.".
- Q424751 atcPrefix "D11".
- Q424751 atcSuffix "AX16".
- Q424751 bioavailability "100.0".
- Q424751 casNumber "70052-12-9".
- Q424751 chEBI "41948".
- Q424751 drugbank "DB06243".
- Q424751 fdaUniiCode "ZQN1G5V6SR".
- Q424751 iupacName "(RS)-2,5-diamino-2-(difluoromethyl)pentanoic acid".
- Q424751 pubchem "3009".
- Q424751 thumbnail (±)-Eflornithin_Structural_Formulae_V.1.svg?width=300.
- Q424751 wikiPageExternalLink en.sanofi-aventis.com.
- Q424751 wikiPageExternalLink index.jsp.
- Q424751 wikiPageExternalLink 1756-3305-3-15.pdf.
- Q424751 wikiPageExternalLink bjc2013280a.html.
- Q424751 wikiPageExternalLink www.vaniqa.com.
- Q424751 wikiPageExternalLink eflornithine.htm.
- Q424751 wikiPageWikiLink Q1074.
- Q424751 wikiPageWikiLink Q11000047.
- Q424751 wikiPageWikiLink Q12140.
- Q424751 wikiPageWikiLink Q1351381.
- Q424751 wikiPageWikiLink Q1368197.
- Q424751 wikiPageWikiLink Q158205.
- Q424751 wikiPageWikiLink Q1620594.
- Q424751 wikiPageWikiLink Q203133.
- Q424751 wikiPageWikiLink Q204711.
- Q424751 wikiPageWikiLink Q25235.
- Q424751 wikiPageWikiLink Q37155.
- Q424751 wikiPageWikiLink Q411582.
- Q424751 wikiPageWikiLink Q416206.
- Q424751 wikiPageWikiLink Q419753.
- Q424751 wikiPageWikiLink Q425946.
- Q424751 wikiPageWikiLink Q49330.
- Q424751 wikiPageWikiLink Q494483.
- Q424751 wikiPageWikiLink Q585285.
- Q424751 wikiPageWikiLink Q6279182.
- Q424751 wikiPageWikiLink Q640448.
- Q424751 wikiPageWikiLink Q7164756.
- Q424751 wikiPageWikiLink Q8256456.
- Q424751 wikiPageWikiLink Q864868.
- Q424751 wikiPageWikiLink Q9052323.
- Q424751 wikiPageWikiLink Q9052781.
- Q424751 wikiPageWikiLink Q931579.
- Q424751 wikiPageWikiLink Q9377.
- Q424751 atcPrefix "D11".
- Q424751 atcSuffix "AX16".
- Q424751 bioavailability "100.0".
- Q424751 bioavailability "Negligible".
- Q424751 casNumber "70052".
- Q424751 chebi "41948".
- Q424751 drugbank "DB06243".
- Q424751 iupacName "-25".
- Q424751 pubchem "3009".
- Q424751 unii "ZQN1G5V6SR".
- Q424751 type ChemicalSubstance.
- Q424751 type Drug.
- Q424751 type ChemicalObject.
- Q424751 type Thing.
- Q424751 type Q8386.
- Q424751 comment "Eflornithine (α-difluoromethylornithine or DFMO) is a drug found to be effective in the treatment of facial hirsutism (excessive hair growth) as well as in African trypanosomiasis (sleeping sickness). Eflornithine hydrochloride cream for topical application is meant for women affected by facial hirsutism. Eflornithine for injection against sleeping sickness is manufactured by Sanofi Aventis and sold under the brand name Ornidyl in the USA.".
- Q424751 label "Eflornithine".
- Q424751 depiction (±)-Eflornithin_Structural_Formulae_V.1.svg.